News
Incyte Corp's new chief executive, Bill Meury, outlined a growth strategy on Tuesday focused on accelerating drug development and prudent capital allocation, as the company faces the looming patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results